- Home
- STTK vs FTEK Comparison
STTK vs FTEK Comparison
Compare STTK & FTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- FTEK
- Stock Information
- Founded
- STTK 2016
- FTEK 1987
- Country
- STTK United States
- FTEK United States
- Employees
- STTK N/A
- FTEK N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- FTEK Pollution Control Equipment
- Sector
- STTK Health Care
- FTEK Industrials
- Exchange
- STTK Nasdaq
- FTEK Nasdaq
- Market Cap
- STTK 83.8M
- FTEK 79.1M
- IPO Year
- STTK 2020
- FTEK N/A
- Fundamental
- Price
- STTK $2.14
- FTEK $3.28
- Analyst Decision
- STTK Hold
- FTEK Strong Buy
- Analyst Count
- STTK 6
- FTEK 1
- Target Price
- STTK $2.67
- FTEK $4.00
- AVG Volume (30 Days)
- STTK 1.5M
- FTEK 321.4K
- Earning Date
- STTK 11-13-2025
- FTEK 11-05-2025
- Dividend Yield
- STTK N/A
- FTEK N/A
- EPS Growth
- STTK N/A
- FTEK N/A
- EPS
- STTK N/A
- FTEK N/A
- Revenue
- STTK $2,997,000.00
- FTEK $25,074,000.00
- Revenue This Year
- STTK N/A
- FTEK $17.16
- Revenue Next Year
- STTK N/A
- FTEK $15.00
- P/E Ratio
- STTK N/A
- FTEK N/A
- Revenue Growth
- STTK N/A
- FTEK N/A
- 52 Week Low
- STTK $0.69
- FTEK $0.87
- 52 Week High
- STTK $3.95
- FTEK $3.65
- Technical
- Relative Strength Index (RSI)
- STTK 58.93
- FTEK 53.37
- Support Level
- STTK N/A
- FTEK N/A
- Resistance Level
- STTK $2.01
- FTEK $3.65
- Average True Range (ATR)
- STTK 0.21
- FTEK 0.22
- MACD
- STTK 0.01
- FTEK -0.08
- Stochastic Oscillator
- STTK 99.53
- FTEK 89.86
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
About FTEK Fuel Tech Inc.
Fuel Tech Inc is an technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.